Breast Cancer Clinical Trial
Official title:
Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors: The FoRtitude Trial
The FoRtitude trial aims to evaluate an eHealth intervention designed to teach breast cancer survivors strategies to manage anxiety about cancer recurrence. The eHealth intervention includes educational content and interactive tools, designed to teach coping strategies and/or inert content, depending on the study participant's randomization assignment. The FoRtitude study will examine whether three coping strategies (relaxation training, cognitive restructuring, worry practice) are more effective than general health-related content in reducing fear of cancer recurrence.
The purpose of the FoRtitude trial is to develop and evaluate a targeted eHealth intervention
designed to teach breast cancer survivors (BCS) coping strategies to manage fear about cancer
recurrence (FoR). FoRtitude, a web-based program with interactive text messaging
capabilities, was created to deliver a targeted intervention for BCS with moderate to severe
FoR. FoRtitude consists of didactic content presented in written and video-based formats and
interactive tools, designed to teach coping strategies. Commonly used cognitive behavior
therapy (CBT) techniques were tailored to the management of FoR and included diaphragmatic
breathing and relaxation, cognitive restructuring, and scheduled worry practice. Participants
are encouraged to use the FoRtitude site several times per week over a period of 4 weeks. The
investigators employed principles of user-centered design to create the FoRtitude website and
incorporated feedback from 17 BCS to refine site content and improve FoRtitude usability.
After refining the FoRtitude site, the investigators will conduct a randomized controlled
trial using the Multiphase Optimization Strategy (MOST) to individually evaluate three coping
strategies; each coping strategy will be compared to health management content. Inert content
includes general health information and managing comorbid illnesses, information on general
nutrition, and information on nutritional topics of interest to BCS. Half of the participants
will be randomized to receive telecoaching, which included 3-4 telephone-based brief sessions
with a motivational interviewer, aimed at improving adherence to use of the FoRtitude site.
Participants will complete questionnaires at baseline, 4 weeks (immediately after completing
the FoRtitude site) and at 8 weeks.
Study hypotheses:
1. BCS randomized to Relaxation training will report a greater reduction in fear of cancer
recurrence from pre-post intervention than BCS randomized to inert (health management)
content
2. BCS randomized to Cognitive restructuring will report a greater reduction in fear of
cancer recurrence from pre-post intervention than BCS randomized to inert (health
management) content
3. BCS randomized to Scheduled Worry practice will report a greater reduction in fear of
cancer recurrence from pre-post intervention than BCS randomized to inert (health
management) content
4. BCS randomized to receive Telecoaching will demonstrate higher adherence to using the
FoRtitude site and will report a greater reduction in fear of cancer recurrence from
pre-post intervention compared to BCS randomized to no Telecoaching
5. BCS randomized to a higher number of coping strategies will report a greater reduction
in fear of cancer recurrence from pre-post intervention than BCS randomized to receive
all inert content or fewer coping strategies (dose-response effect)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |